We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+14.93%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$73.9B
AUM Growth
+$5.6B
Cap. Flow
-$3.28B
Cap. Flow %
-4.43%
Top 10 Hldgs %
14.52%
Holding
790
New
69
Increased
319
Reduced
276
Closed
94

Top Sells

Rank Stock Value
1
COP icon
ConocoPhillips
COP
+$683M
2
META icon
Meta Platforms (Facebook)
META
+$428M
3
SLB icon
SLB Ltd
SLB
+$322M
4
D icon
Dominion Energy
D
+$239M
5
AZO icon
AutoZone
AZO
+$237M

Sector Composition

Rank Sector Weight
1 Financials 19.15%
2 Healthcare 17.66%
3 Industrials 15.13%
4 Technology 13.58%
5 Consumer Discretionary 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$646B
$1.53B 2.07%
8,674,076
-366,795
-4% -$63.3M
JPM icon
2
JPMorgan Chase
JPM
$925B
$1.31B 1.77%
9,766,485
-297,433
-3% -$37.7M
AZO icon
3
AutoZone
AZO
$51.4B
$1.3B 1.77%
528,970
-98,165
-16% -$237M
CI icon
4
Cigna
CI
$79B
$1.06B 1.44%
3,214,614
-159,330
-5% -$50.4M
BMY icon
5
Bristol-Myers Squibb
BMY
$130B
$992M 1.34%
13,794,089
+3,627,705
+36% +$274M
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.1T
$984M 1.33%
3,184,311
+203,932
+7% +$60.6M
SLB icon
7
SLB Ltd
SLB
$73.2B
$930M 1.26%
17,368,855
-6,469,747
-27% -$322M
SNY icon
8
Sanofi
SNY
$109B
$884M 1.2%
18,246,904
+523,705
+3% +$23M
DD icon
9
DuPont de Nemours
DD
$18.5B
$877M 1.19%
10,156,674
+198,340
+2% +$15.8M
COR icon
10
Cencora
COR
$62.5B
$861M 1.17%
5,201,488
+159,849
+3% +$25.3M
CNC icon
11
Centene
CNC
$31.3B
$838M 1.13%
10,247,108
-1,283,376
-11% -$105M
SCHW
12
Charles Schwab
SCHW
$184B
$831M 1.12%
10,012,972
-342,714
-3% -$26.6M
UNH icon
13
UnitedHealth
UNH
$387B
$830M 1.12%
1,569,497
-41,128
-3% -$21.8M
COP icon
14
ConocoPhillips
COP
$144B
$827M 1.12%
7,010,577
-5,615,079
-44% -$683M
HWM icon
15
Howmet Aerospace
HWM
$111B
$826M 1.12%
20,939,613
-173,259
-0.8% -$6.32M
ABBV icon
16
AbbVie
ABBV
$471B
$817M 1.11%
5,068,807
-1,081,267
-18% -$166M
CVS icon
17
CVS Health
CVS
$137B
$809M 1.09%
8,706,023
+671,235
+8% +$64.8M
MPC icon
18
Marathon Petroleum
MPC
$90.4B
$803M 1.09%
6,884,999
-1,074,421
-13% -$122M
CSCO icon
19
Cisco
CSCO
$452B
$782M 1.06%
16,398,508
+1,144,033
+7% +$52.1M
CNP icon
20
CenterPoint Energy
CNP
$28.7B
$754M 1.02%
25,132,753
+68,199
+0.3% +$1.98M
KDP icon
21
Keurig Dr Pepper
KDP
$42.6B
$747M 1.01%
20,943,400
+784,704
+4% +$29.4M
GOOGL icon
22
Alphabet (Google) Class A
GOOGL
$4.09T
$707M 0.96%
7,957,728
+308,483
+4% +$29.3M
EG icon
23
Everest Group
EG
$15.8B
$695M 0.94%
2,096,090
-491,433
-19% -$153M
WFC icon
24
Wells Fargo
WFC
$257B
$690M 0.93%
16,590,738
+406,565
+3% +$18M
BAC icon
25
Bank of America
BAC
$431B
$686M 0.93%
20,633,422
+1,403,344
+7% +$48.3M

Similar funds

Boston Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Boston Partners held 790 positions worth $73.9B, up 8.2% from $68.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Boston Partners withdrew a net $3.28B in Q4 2022, closing 94 positions and reducing 276 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $428M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Boston Partners opened a new position in Prologis worth $156M.

  • Boston Partners's largest Q4 2022 buy was Prologis: 1,379,952 shares worth $156M.
  • Boston Partners added most to Bristol-Myers Squibb in Q4 2022, an estimated $274M increase.
  • Boston Partners's biggest Q4 2022 reduction was ConocoPhillips, cutting an estimated $683M.
  • Boston Partners fully exited Meta Platforms (Facebook) in Q4 2022, selling an estimated $428M.
  • Boston Partners's ten largest holdings make up 15% of its $73.9B portfolio in Q4 2022.
  • Boston Partners opened 69 new positions and closed 94 in Q4 2022.
  • Boston Partners's portfolio value rose 8.2% quarter-over-quarter to $73.9B.

Based on Boston Partners's 13F filing for Q4 2022, filed 8 Feb 2023.